Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...

Escalating from last month’s internal warnings of rough vibes, OpenAI CEO Sam Altman has declared a company-wide “Code Red” to salvage his flagship product. As a result, the “Pulse” personal assistant ...

Google’s own ‘code red’ response to ChatGPT has started paying off. Google’s own ‘code red’ response to ChatGPT has started paying off. is a London-based reporter at The Verge covering all things AI ...

SetPoint System® is first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis SetPoint Medical, a commercial-stage medical ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Support our Mission. We independently test each product we recommend. When you buy through our links, we may earn a commission. Welcome back, my friends, to the show that never ends. It’s time for ...

November 4, 2025—Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States pivotal study for pulsatile intravascular lithotripsy (IVL) ...